T1	Participants 86 114	lower urinary tract symptoms
T2	Participants 919 972	45 years old or older with total I-PSS 13 or greater.
T3	Participants 1467 1628	742 tadalafil treated patients 513 (69.1%) and 444 (59.8%) demonstrated category 1 and 2 clinically meaningful improvement, respectively, at the study end point.
T4	Participants 2136 2164	lower urinary tract symptoms
